Establishment Registration & Device Listing

Establishment Registration Number : 1119779 Product Code : LON

Establishment Name	Registration Number	Current Registration Yr
BECTON, DICKINSON & CO. MD/USA	1119779	2013
system, test, automated, antimicrobial susceptibility, short incubation - Amikacin GN 0.5-64 µg		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5/0.25-32/16 µg/mL; Amoxicillin/Clauvulanate GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5/0.25-32/16 µg/mL; 1-128 µg/mL; Amoxicillin/Clauvulanate GN; Ampicillin/Sulbactam GN; MIC Reporting; Ticarcillin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25/.12-32/16 µg/mL; Amoxicillin/Clauvulante GP; New Drug		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Amoxicillin Strep 0.0313-32 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Ampicillin GN 0.5-32 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Ampicillin GN 0.5-32 µg/mL; MIC Reporting		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Ampicillin GP 0.0625-32 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5/0.25-32/16 µg/mL; Ampicillin/Sulbactam GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1/0.5-32/16 µg/mL; Ampicillin/Sulbactam GN; Limitation removal/ID algorithm		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 2/1 - 32/16 µg/mL; Ampicillin/Sulbactam GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Aztreonam GN 0.5-64 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Aztreonam GN 0.5-64 µg/mL; New formulation		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Cefazolin GP 2-32 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Cefazolin GN 0.5-32 µg/mL; Focused/New Drug		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Cefazolin GN 0.5-32 µg/mL; New Formulation		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-4 µg/mL; Cefepime Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Cefepime GN 0.5-64 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-64 µg/mL; Cefepime GN 0.5-64 µg/mL; Ceftriaxone GN; MIC Reporting		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Cefepime GN 0.5-64 µg/mL; New Formulation		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Cefotazime GN 0.5-64 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Cefotaxime Strep 0.0625-4 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Cefotetan GN 2-64 µg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-32 µg/mL; Cefoxitin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-64 µg/mL; Cefoxitin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-64 µg/mL; Cefoxitin GN; MIC Reporting		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-8 µg/mL; Cefpodoxime GN; ID algorithm; Limitation Removal		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-64 µg/mL; Ceftazidime GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-64 µg/mL; Ceftazidime GN; Limitation Removal Process Change		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-64 µg/mL; Ceftazidime GN ; LR P. aeruginosa		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-4 µg/mL; Ceftriaxone Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-64 µg/mL; Ceftriaxone GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Ceftriaxone GN 0.5-64 µg/mL; ID aigorithm; Limitation Removal		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-64 µg/mL; Cefuroxime GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-64 µg/mL; Cefuroxime LR		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-4 µg/mL; Cefuroxime Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-64 µg/mL; Cephalothin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-64 µg/mL; Cephalothin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-64 µg/mL; Cephalothin GN; MIC reporting		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-32 µg/mL; Chloramphenicol GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-8 µg/mL; 0.25-4 µg/mL; 1-32 µg/mL; Chloramphenicol GP; Erythromycin GP; Quinupristin/Dalfopristin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-4 µg/mL; Ciprofloxacin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-4 µg/mL; Ciprofloxacin LR GN; Enterobacter, Serratia		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-8 µg/mL; 0.25-4 µg/mL; Ciprofloxacin GN; MIC Reporting; Moxifloxacin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-8 µg/mL; Clindamycin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0313-4µg/mL ; Clindamycin Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-32 µg/mL; Daptomycin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-32 µg/mL; Ertapenem GN; New Drug		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-8 µg/mL; Erthromycin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0156-4 µg/mL; Erythromycin Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - ESBL GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-8µg/mL; AST Broth & AST Indicator; BD Phoenix 100 Instrument; BD Phx 100 instru, Remfrd Resale; Gatifloxacin GN; Gatifloxacin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-8 µg/mL; Gatifloxacin GN; MIC Reporting		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-8 µg/mL; Gatifloxacin Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-16 µg/mL; Gentamicin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-16 µg/mL; Gentamicin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1000 µg/mL; 500 µg/mL; Gentamicin-Syn GP; Streptomycin-Synergy GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-16 µg/mL; Imipenem GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-8 µg/mL; Levofloxacin GN; Levofloxacin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-16µg/mL ; Levofloxacin Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-32 µg/mL; Linezolid GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-16 µg/mL; Linezolid Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-16 µg/mL; Meropenem GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-16 µg/mL; Meropenem GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0313-2 µg/mL; Meropenem Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-32 mg/mL; Minocycline GN; New Drug		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-32 mg-mL; Minocycline GP; New Drug		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-8 µg/mL; Moxifloxacin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-8 µg/mL; Moxifloxacin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-8 µg/mL; Moxifloxacin Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 2-32 µg/mL; Nalidixic Acid GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5/9.5-16/304 µg/mL; 2-32µg/mL; 8-512 µg/mL; MIC Reporting; Naladixic Acid GN; Nitrofurantoin GN; Trimethoprim/Sulfa GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 16-512 µg/mL; Nitrofurantoin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 8-512 µg/mL; Nitrofurantoin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-16 µg/mL; Norfloxacin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-16 µg/mL; Norfloxacin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-8 µg/mL; Ofloxacin GN; Ofloxacin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-4 µg/mL; Oxacillin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0156-32µg/mL ; Penicillin Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-32 µg/mL; Penicillin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Phoenix/EpiCenter		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-128 µg/mL; Piperacillin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1/4-128/4 µg/mL; Piperacillin/Tazobactam GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5/4-128/4 µg/mL; Piperacillin/Tazobactam GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-16 µg/mL; Tetracycline GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-16 µg/mL; MIC Reporting; Tetracycline GP; Tetracycline GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-16 µg/mL; Tetracycline GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625-16 µg/mL; Tetracycline Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-128 µg/mL; Ticarcillin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1-128 µg/mL; ID algorithm; Limitation Removal ; Ticarcillin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1/2-12//2 µg/mL; Ticarcillin/Clav GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 1/2-128/2 µg/mL; Limitation Removal process change; Ticarcillin/clavulanate GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.125-16 µg/mL; Tobramycin GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-16 µg/mL; Tobramycin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-16 µg/mL; Trimethoprim GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5/9.5-16/304 µg/mL; Trimethoprim/Sulfa GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.0625/1.2-16/304 µg/mL; Trimetoprim/Sulfa Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5/9.5-16/304 µg/mL; Trimethoprim/Sulfa GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-32 µg/mL; Vancomycin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-4 µg/mL; Quinupristin/Dalfopristin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.25-32 µg/mL; Rifampin GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - 0.5-32 µg/mL; Limitation removal ; Vancomycin - detection of VRSA; VRSA GP		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - AST-S Broth & AST-S Indicator; Vancomycin Strep		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Piperacillin (2-128 mcg ) GN		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Daptomycin 0.0313-16 mcg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Doxycycline (GP) 0.25-16 mcg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Mulitple Phoenix ID/AST Panels		U.S. Manufacturer of Export Only Devices
system, test, automated, antimicrobial susceptibility, short incubation - Nitrofurantoin (GP) 4-128 mcg/mL		Manufacturer
system, test, automated, antimicrobial susceptibility, short incubation - Phoenix iMLSb Test (GP)		Manufacturer

Can't find what you're looking for?  Try a new search